BioAffinity Technologies Inc

NASDAQ: BIAF    
Share price (5/17/24): $2.26    
Market cap (5/17/24): $26.3 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 3 pages Support Agreement
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K ~1 page Amendment to Offer Letter
12/34/56
EX-10.1
from 8-K 5 pages BioAffinity Technologies, Inc. Management Incentive Bonus Plan
12/34/56
EX-10.1
from 8-K 1 page December 1, 2023 Dr. Jamie Platt DR.JAMIE.PLATT@GMAIL.com Sincerely, Accepted This 1st Day of December, 2023 /S/ Maria Zannes /S/ Jamie Platt Maria Zannes Jamie Platt, Phd Director, President & CEO
12/34/56
EX-10.13
from 8-K 2 pages Bill of Sale
12/34/56
EX-10.12
from 8-K 19 pages Strategic Relationship and License Agreement
12/34/56
EX-10.11
from 8-K 13 pages Material contract
12/34/56
EX-10.10
from 8-K 22 pages Material contract
12/34/56
EX-10.9
from 8-K 2 pages Assignment and Assumption Agreement
12/34/56
EX-10.8
from 8-K 23 pages Office Lease
12/34/56
EX-10.7
from 8-K 3 pages Assignment and Assumption of Lease Agreement
12/34/56
EX-10.6
from 8-K 8 pages Executive Employment Agreement
12/34/56
EX-10.5
from 8-K 6 pages Professional Services Agreement
12/34/56
EX-10.4
from 8-K 19 pages Succession Agreement
12/34/56
EX-10.3
from 8-K 25 pages Management Services Agreement
12/34/56
EX-10.2
from 8-K 15 pages BioAffinity Technologies, Inc. Subscription Agreement
12/34/56
EX-10.1
from 8-K 38 pages Asset Purchase Agreement by and Among Precision Pathology Laboratory Services, LLC Village Oaks Pathology Services, P.A., and Roby P. Joyce, M.D. Effective as of September 18, 2023
12/34/56
EX-10.1
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.1
from 8-K 13 pages BioAffinity Technologies, Inc. Amended and Restated 2014 Equity Incentive Plan
12/34/56